Sharing and Selling of Prescription Medications in a College Student Sample

Center for Substance Abuse Research, University of Maryland, College Park, MD 20740, USA.
The Journal of Clinical Psychiatry (Impact Factor: 5.5). 03/2010; 71(3):262-9. DOI: 10.4088/JCP.09m05189ecr
Source: PubMed


To estimate the prevalence of prescription medication diversion among college students; to compare classes of medications with respect to the likelihood of diversion; to document the most common methods of diversion; and to examine the characteristics of students who diverted medications.
A cross-sectional analysis of personal interview data collected between August 2006 and August 2007 as part of an ongoing longitudinal study. The cohort of students, who were between the ages of 17 and 19 years at study onset, attended a large public university in the mid-Atlantic region. Information was gathered regarding a wide variety of variables, including demographics, diversion of medically prescribed drugs, illicit drug use, and childhood conduct problems.
Among 483 students prescribed a medication, 35.8% diverted a medication at least once in their lifetime. The most commonly diverted medication classes were prescription attention-deficit/hyperactivity disorder medication (61.7% diversion rate) and prescription analgesics (35.1% diversion rate). Sharing was the most common method of diversion, with 33.6% of students sharing their medication(s) and 9.3% selling in their lifetime. Comparative analyses revealed that prescription medication diverters had used more illicit drugs in the past year and had more childhood conduct problems than nondiverters.
If confirmed, these findings have important clinical implications for improved physician-patient communication and vigilance regarding prescribing analgesic and stimulant medications for young adults.

  • Source
    • "In 2011, 11% of children 4–17 years old (6.4 million) had at some point in their lives been diagnosed with attention deficit hyperactivity disorder (ADHD), and 3.5 million were taking ADHD medication (Visser et al., 2014). Illicit use of these prescribed medications among young adults without ADHD and of designer synthetic cathinones such as " bath salts " is also an increasing problem (Garnier et al., 2010; Lakhan and Kirchgessner, 2012; Wood, 2013). Over-the-counter decongestants and herbal products targeting weight loss may contain pseudoephedrine, ephedrine, and phenylpropanolamine and have been associated with morbidity and mortality even when taken at correct dosage (Gunn et al., 2001). "
    [Show abstract] [Hide abstract] ABSTRACT: Overdose of amphetamine, related derivatives, and analogues (ARDA) continues to be a serious worldwide health problem. Patients frequently present to the hospital and require treatment for agitation, psychosis, and hyperadrenegic symptoms leading to pathologic sequelae and mortality. To review the pharmacologic treatment of agitation, psychosis, and the hyperadrenergic state resulting from ARDA toxicity. MEDLINE, PsycINFO, and the Cochrane Library were searched from inception to September 2014. Articles on pharmacologic treatment of ARDA-induced agitation, psychosis, and hyperadrenergic symptoms were selected. Evidence was graded using Oxford CEBM. Treatment recommendations were compared to current ACCF/AHA guidelines. The search resulted in 6082 articles with 81 eligible treatment involving 835 human subjects. There were 6 high-quality studies supporting the use of antipsychotics and benzodiazepines for control of agitation and psychosis. There were several case reports detailing the successful use of dexmedetomidine for this indication. There were 9 high-quality studies reporting the overall safety and efficacy of β-blockers for control of hypertension and tachycardia associated with ARDA. There were 3 high-quality studies of calcium channel blockers. There were 2 level I studies of α-blockers and a small number of case reports for nitric oxide-mediated vasodilators. High-quality evidence for pharmacologic treatment of overdose from ARDA is limited but can help guide management of acute agitation, psychosis, tachycardia, and hypertension. The use of butyrophenone and later-generation antipsychotics, benzodiazepines, and β-blockers is recommended based on existing evidence. Future randomized prospective trials are needed to evaluate new agents and further define treatment of these patients. Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
    Full-text · Article · Feb 2015 · Drug and Alcohol Dependence
  • Source
    • "The use of psychoactive prescription drugs (PPDs) by young people for recreation and self-enhancement is a global concern, especially in the United States (US) where surveys suggest that nearly one-third of the population aged between 18 and 25 has used PPDs for non-medical reasons at least once in their lifetime (Colliver, Kroutil, Lantung, & Gfroerer, 2006; DuPont, 2010; SAMHSA, 2009). Numerous studies in the US have also shown that young people are key actors in the diffusion of stimulants, pain killers and tranquilizers (Garnier et al., 2010; Hall, Irwin, Bowman, Frankenberger, & Jewett, 2005; McCabe, Teter, & Boyd, 2006; Quintero & Nichter, 2011; Rasmussen, 2008). "
    [Show abstract] [Hide abstract] ABSTRACT: The use of psychoactive prescription drugs (PPDs) by young people is part of a broader worldwide trend towards the consumption of pharmaceuticals to improve social, emotional, and sexual performance. Few studies have examined how young people use PPDs in developing countries, where off-label use is likely to be greater due to weaker market controls. This study presents our findings on PPD use among sex workers in Makassar, Indonesia. We focus on one potent painkiller, Somadril, which is freely available over the counter in pharmacies. The sex workers we studied used most of their earnings to purchase Somadril pills, which they used to feel more confident and to make their work more palatable. This paper also traces the history of the active component in Somadril, carisoprodol. This was developed in the United States, where it was soon used recreationally. We found that knowledge of its effects seeped from health professionals into youth networks, where it was spread by word of mouth. The flow of information on carisoprodol's harmful effects, however, was less evident.
    Full-text · Article · Jul 2014 · International Journal of Drug Policy
  • Source
    • "nondistributors) experience more hyperactivity symptoms with their ADHD and more likely to be high sensation-seekers. While the work of Garnier et al. (2010) Jardin et al. (2011), and Sepúlveda et al. (2011) have contributed to our understanding of the characteristics of ADHD distributors , a more complex and layered profile is needed. Consequently, it is the purpose of this study to identify indicators of students, with current prescriptions to ADHD stimulants, who are most likely to illegally distribute their ADHD medication to their nonprescribed peers. "
    [Show abstract] [Hide abstract] ABSTRACT: This study identifies indicators of college students, with prescriptions to Attention Deficit Hyperactivity Disorder (ADHD) stimulants, who are most likely to distribute their medication to nonprescribed peers. 2,313 undergraduate students at a large Southeastern University were surveyed from 2009 to 2011. 5.2% (n = 120) were currently taking a prescribed ADHD stimulant. Analyses revealed that distributors are more likely to (1) take their medication less frequently; (2) misuse their stimulants for "off label" purposes; (3) be a member of a fraternity; (4) overestimate the percentages of users; and (5) belong to at-risk peer groups. The work concludes by discussing the study's implications, limitations and future research.
    Full-text · Article · Apr 2013 · Substance Use & Misuse
Show more